Detalhe da pesquisa
1.
An autoantibody signature predictive for multiple sclerosis.
Nat Med
; 30(5): 1300-1308, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641750
2.
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.
Mult Scler Relat Disord
; 70: 104484, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608538
3.
A Predictive Autoantibody Signature in Multiple Sclerosis.
medRxiv
; 2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205595
4.
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function.
JCI Insight
; 7(4)2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030101
5.
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis.
Mult Scler Relat Disord
; 56: 103251, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34571415
6.
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity.
medRxiv
; 2021 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580672